title: The thin red line: angiogenesis in normal and malignant hematopoiesis.
abstract: This review describes the current knowledge about cell subsets involved in vasculogenesis (i.e., differentiation of endothelial cells from mesodermal precursors) and angiogenesis (i.e., blood vessel generation from pre-existing vessels), together with recent findings about angiogenesis and antiangiogenic therapies in hematopoietic malignancies such as leukemia, lymphoma, myeloma, and myelodysplastic syndromes.
authors.affiliation: Division of Hematology-Oncology, IRCCS European Institute of Oncology, Milan, Italy. francesco.bertolini@ieo.it
authors.forename: F
authors.initials: F
authors.lastname: Bertolini
authors.forename: P
authors.initials: P
authors.lastname: Mancuso
authors.forename: A
authors.initials: A
authors.lastname: Gobbi
authors.forename: G
authors.initials: G
authors.lastname: Pruneri
mesh_terms: D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology; D019337:Hematologic Neoplasms / Q000503:physiopathology*; D006410:Hematopoiesis / Q000502:physiology; D006801:Humans; D009389:Neovascularization, Pathologic / Q000503:physiopathology*; D018919:Neovascularization, Physiologic / Q000502:physiology; D013234:Stem Cells / Q000276:immunology / Q000502:physiology
chemical_list: D000970:Antineoplastic Agents